Angiopoietin-Like Protein 2 and Risk of Type 2 Diabetes in a General Japanese Population The Hisayama Study

被引:105
作者
Doi, Yasufumi [1 ,2 ]
Ninomiya, Toshiharu [1 ,2 ]
Hirakawa, Yoichiro [1 ,2 ]
Takahashi, Otowa [3 ]
Mukai, Naoko [1 ,2 ]
Hata, Jun [1 ,2 ]
Iwase, Masanori [1 ]
Kitazono, Takanari [1 ]
Oike, Yuichi [3 ]
Kiyohara, Yutaka [2 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Environm Med, Fukuoka 812, Japan
[3] Kumamoto Univ, Grad Sch Med Sci, Dept Mol Genet, Kumamoto, Japan
基金
日本学术振兴会;
关键词
INSULIN-RESISTANCE; INFLAMMATION; ATHEROSCLEROSIS; ASSOCIATION; EXPRESSION; DIAGNOSIS; MELLITUS; MARKERS; DISEASE;
D O I
10.2337/dc12-0166
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
OBJECTIVE-To examine, for the first time, the association between a novel inflammatory cytokine, angiopoietin-like protein (ANGPTL) 2, and the development of type 2 diabetes (T2DM). RESEARCH DESIGN AND METHODS-A total of 2,164 community-dwelling Japanese individuals aged 40 to 79 years without diabetes were followed up for 7 years. Serum ANGPTL2 levels were divided into quartile categories at baseline: <2.15, 2.16-2.71, 2.72-3.40, and >= 3.41 ng/mL. During follow-up, 221 participants developed T2DM. RESULTS-In multivariate analyses, after adjusting for comprehensive risk factors and high-sensitivity C-reactive protein (hs-CRP) levels, the risk of developing T2DM was significantly higher in the highest ANGPTL2 quartile than in the lowest quartile (hazard ratio, 1.80; 95% CI, 1.14-2.85; P = 0.01). CONCLUSIONS-Elevated serum ANGPTL2 levels were positively associated with the development of T2DM in a general population, independent of other risk factors including hs-CRP levels. Diabetes Care 36: 98-100, 2013
引用
收藏
页码:98 / 100
页数:3
相关论文
共 15 条
[1]
Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population - The Hisayama Study [J].
Doi, Y ;
Kiyohara, Y ;
Kubo, M ;
Ninomiya, T ;
Wakugawa, Y ;
Yonemoto, K ;
Iwase, M ;
Iida, M .
DIABETES CARE, 2005, 28 (10) :2497-2500
[2]
Fasting plasma glucose cutoff for diagnosis of diabetes in a Japanese population [J].
Doi, Yasufumi ;
Kubo, Michiaki ;
Yonemoto, Koji ;
Ninomiya, Toshiharu ;
Iwase, Masanori ;
Arima, Hisatomi ;
Hata, Jun ;
Tanizaki, Yumihiro ;
Iida, Mitsuo ;
Kiyohara, Yutaka .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (09) :3425-3429
[3]
The epidemiology of low-grade chronic systemic inflammation and type 2 diabetes [J].
Duncan, Bruce B. ;
Schmidt, Maria Ines .
DIABETES TECHNOLOGY & THERAPEUTICS, 2006, 8 (01) :7-17
[4]
Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes - The insulin resistance atherosclerosis study [J].
Festa, A ;
D'Agostino, R ;
Tracy, RP ;
Haffner, SM .
DIABETES, 2002, 51 (04) :1131-1137
[5]
Genuth S, 2003, DIABETES CARE, V26, P3160
[6]
Hepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin-related protein that prevents endothelial-cell apoptosis [J].
Kim, I ;
Kim, HG ;
Kim, H ;
Kim, HH ;
Park, SK ;
Uhm, CS ;
Lee, ZH ;
Koh, GY .
BIOCHEMICAL JOURNAL, 2000, 346 (pt 3) :603-610
[7]
Molecular cloning, expression, and characterization of angiopoietin-related protein - Angiopoietin-related protein induces endothelial cell sprouting [J].
Kim, I ;
Moon, SO ;
Koh, KN ;
Kim, H ;
Uhm, CS ;
Kwak, HJ ;
Kim, NG ;
Koh, GY .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (37) :26523-26528
[8]
Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy [J].
Oike, Y ;
Akao, M ;
Kubota, Y ;
Suda, T .
TRENDS IN MOLECULAR MEDICINE, 2005, 11 (10) :473-479
[9]
Synoviocyte-Derived Angiopoietin-Like Protein 2 Contributes to Synovial Chronic Inflammation in Rheumatoid Arthritis [J].
Okada, Tatsuya ;
Tsukano, Hiroto ;
Endo, Motoyoshi ;
Tabata, Mitsuhisa ;
Miyata, Keishi ;
Kadomatsu, Tsuyoshi ;
Miyashita, Kazuya ;
Semba, Kei ;
Nakamura, Eiichi ;
Tsukano, Michishi ;
Mizuta, Hiroshi ;
Oike, Yuichi .
AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (05) :2309-2319
[10]
Markers of inflammation and cardiovascular disease application to clinical and public health practice - A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association [J].
Pearson, TA ;
Mensah, GA ;
Alexander, RW ;
Anderson, JL ;
Cannon, RO ;
Criqui, M ;
Fadl, YY ;
Fortmann, SP ;
Hong, Y ;
Myers, GL ;
Rifai, N ;
Smith, SC ;
Taubert, K ;
Tracy, RP ;
Vinicor, F .
CIRCULATION, 2003, 107 (03) :499-511